HomeCare September 18, 2024
CCS Medical research reveals diabetes patients receiving a CGM through a medical benefit had lower costs of care, higher device adherence & longer therapy attendance
DALLAS—CCS Medical, a clinical solutions and home-delivered medical supplies provider, announced new research results which found patients living with diabetes who use a continuous glucose monitoring (CGM) device stay on therapy longer and have a lower total cost of care when they receive their supplies through a medical benefit.
The peer-reviewed study, published in the Journal of Medical Internet Research Diabetes (JMIR), used a retrospective claims analysis to demonstrate that patients receiving CGM through a medical benefit instead of a pharmacy had 35% lower average annual total costs of care and 23% higher device...
Today's Sponsors
Today's Sponsor